BE

BIMZELX® Approved by the U.S. FDA for the Treatment of Adults with Moderate-to-Severe Plaque Psoriasis

Retrieved on: 
Wednesday, October 18, 2023
Science, Patient, FDA, UCB, National Psoriasis Foundation, Psoriasis, Week, Icahn School of Medicine at Mount Sinai, Plaque, Food, Observational study, MD, Information, Skin, Cytokine, BE, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Bimekizumab, Jeff Flake, Mount Sinai, Adalimumab, Ustekinumab, Safety, Therapy, Pharmaceutical industry, Medical imaging, Dermatology, Medicine

"With BIMZELX now approved for psoriasis, we will move forward rapidly to submit applications for additional indications in the U.S."

Key Points: 
  • "With BIMZELX now approved for psoriasis, we will move forward rapidly to submit applications for additional indications in the U.S."
    "We have been eagerly awaiting bimekizumab, the first IL-17A and IL-17F inhibitor, to be approved in the U.S. for the treatment of adults with moderate-to-severe plaque psoriasis.
  • "The approval of bimekizumab will provide an important new treatment option for adults living with moderate-to-severe plaque psoriasis," said Leah McCormick Howard, J.D., President and CEO for the National Psoriasis Foundation.
  • "Our hope is that new treatments translate into improved outcomes for many and help alleviate the physical and emotional burden of psoriasis."
  • For additional medical information, patient assistance or any other information, please call UCBCares® at 1-844-599-CARE (2273) or visit askucbcares.com .

BE OPEN Launches BE OPEN Everyday Art Open Call to celebrate people's innate creativity

Retrieved on: 
Monday, October 16, 2023
Breakfast, BE, Creativity, Community, Social media, Life, Eye, OPEN, Creative industries

With open calls, by asking the participants to share their vision with pictures and photographs, BE OPEN aims to support creativity as a universal approach, and build bonds between people around the globe.

Key Points: 
  • With open calls, by asking the participants to share their vision with pictures and photographs, BE OPEN aims to support creativity as a universal approach, and build bonds between people around the globe.
  • BE OPEN believes that the ability for creative interpretation is not confined within the art and design industry.
  • We invite you to join our new #BEOPENEverydayArt open call and share the visuals that demonstrate your everyday creativity in order to connect with people worldwide.
  • BE OPEN is a global initiative to foster creativity and innovation supported by international philanthropist and businesswoman Elena Baturina.

BE OPEN Launches BE OPEN Everyday Art Open Call to celebrate people's innate creativity

Retrieved on: 
Monday, October 16, 2023
Breakfast, BE, Creativity, Community, Social media, Life, Eye, OPEN, Creative industries

With open calls, by asking the participants to share their vision with pictures and photographs, BE OPEN aims to support creativity as a universal approach, and build bonds between people around the globe.

Key Points: 
  • With open calls, by asking the participants to share their vision with pictures and photographs, BE OPEN aims to support creativity as a universal approach, and build bonds between people around the globe.
  • BE OPEN believes that the ability for creative interpretation is not confined within the art and design industry.
  • We invite you to join our new #BEOPENEverydayArt open call and share the visuals that demonstrate your everyday creativity in order to connect with people worldwide.
  • BE OPEN is a global initiative to foster creativity and innovation supported by international philanthropist and businesswoman Elena Baturina.

UCB Reinforces Commitment to Advancing Care in Hidradenitis Suppurativa with Six Abstracts at SHSA 2023

Retrieved on: 
Friday, October 13, 2023
Diagnosis, Food, Abstract, Research, UCB, Report of the 1st Annual Symposium on Relaxed Improvisation, Insurance, Safety, Bimekizumab, Hidradenitis suppurativa, Policy, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, BE, Pharmaceutical industry, Pain, Patient, Political moderate, HS

ATLANTA, Oct. 13, 2023 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that it will present six abstracts in hidradenitis suppurativa (HS) at the 8th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA), October 13–15 in Phoenix, Arizona.

Key Points: 
  • ATLANTA, Oct. 13, 2023 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that it will present six abstracts in hidradenitis suppurativa (HS) at the 8th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA), October 13–15 in Phoenix, Arizona.
  • "The data to be presented at SHSA reinforce our commitment to advancing medicines in areas where patients have the greatest need," said Emmanuel Caeymaex, Executive Vice President, Immunology Solutions and Head of U.S., UCB.
  • In a second oral presentation, 48-week data evaluating the impact of bimekizumab on health-related quality of life will be shared.
  • Three poster presentations will include subgroup analyses from the two Phase 3 studies, including 48-week data in U.S. patients.

BE OPEN Art launches the last stage of the regional competition in 2023 to support emerging artists of Central Africa

Retrieved on: 
Friday, October 13, 2023
Star Awards for Most Popular Regional Artiste, Region, Democratic republic, Exhibition, Month, Príncipe, Congo, Lo Nuestro Award for Regional Mexican Male Artist of the Year, Elvis Duran's Artist of the Month, BE, Artist, Film industry, Central Africa

LONDON, Oct. 13, 2023 /PRNewswire/ -- BE OPEN Art , an online art gallery set up by BE OPEN think tank, a humanitarian initiative founded by international businessperson and philanthropist Elena Baturina, is running a new competition for emerging artists, aimed to support those whose art best represents their regional, cultural and ethnic identities – BE OPEN Regional Art.

Key Points: 
  • LONDON, Oct. 13, 2023 /PRNewswire/ -- BE OPEN Art , an online art gallery set up by BE OPEN think tank, a humanitarian initiative founded by international businessperson and philanthropist Elena Baturina, is running a new competition for emerging artists, aimed to support those whose art best represents their regional, cultural and ethnic identities – BE OPEN Regional Art.
  • The fourth stage of the programme this year covers the countries of Central Africa: Cameroon, Central African Republic, Chad, Congo Republic - Brazzaville, Democratic Republic of Congo, Equatorial Guinea, Gabon, São Tomé & Principe.
  • The stage will last three months, and the reginal winner will be named and awarded 500 euro at the end of the year.
  • The first stage of BE OPEN Regional Art was dedicated to the art of the Eastern Mediterranean.

BE OPEN Art launches the last stage of the regional competition in 2023 to support emerging artists of Central Africa

Retrieved on: 
Friday, October 13, 2023
Star Awards for Most Popular Regional Artiste, Region, Democratic republic, Exhibition, Month, Príncipe, Congo, Lo Nuestro Award for Regional Mexican Male Artist of the Year, Elvis Duran's Artist of the Month, BE, Artist, Film industry, Central Africa

LONDON, Oct. 13, 2023 /PRNewswire/ -- BE OPEN Art , an online art gallery set up by BE OPEN think tank, a humanitarian initiative founded by international businessperson and philanthropist Elena Baturina, is running a new competition for emerging artists, aimed to support those whose art best represents their regional, cultural and ethnic identities – BE OPEN Regional Art.

Key Points: 
  • LONDON, Oct. 13, 2023 /PRNewswire/ -- BE OPEN Art , an online art gallery set up by BE OPEN think tank, a humanitarian initiative founded by international businessperson and philanthropist Elena Baturina, is running a new competition for emerging artists, aimed to support those whose art best represents their regional, cultural and ethnic identities – BE OPEN Regional Art.
  • The fourth stage of the programme this year covers the countries of Central Africa: Cameroon, Central African Republic, Chad, Congo Republic - Brazzaville, Democratic Republic of Congo, Equatorial Guinea, Gabon, São Tomé & Principe.
  • The stage will last three months, and the reginal winner will be named and awarded 500 euro at the end of the year.
  • The first stage of BE OPEN Regional Art was dedicated to the art of the Eastern Mediterranean.

BE OPEN Art congratulates the winners of the Regional Art Competition in Southeast Asia

Retrieved on: 
Friday, October 13, 2023
Star Awards for Most Popular Regional Artiste, Pseudonym, Region, Henry Newton (Winsor & Newton founder), Month, Baturin (surname), Love, Drawing, BE, Child, Artist, Interior design, Central Africa

LONDON, Oct. 13, 2023 /PRNewswire/ -- BE OPEN Art , an online art gallery set up by BE OPEN think tank, a humanitarian initiative founded by international businessperson and philanthropist Elena Baturina, is running a new competition for emerging artists, aimed to support those whose art best represents their regional, cultural and ethnic identities – BE OPEN Regional Art.

Key Points: 
  • LONDON, Oct. 13, 2023 /PRNewswire/ -- BE OPEN Art , an online art gallery set up by BE OPEN think tank, a humanitarian initiative founded by international businessperson and philanthropist Elena Baturina, is running a new competition for emerging artists, aimed to support those whose art best represents their regional, cultural and ethnic identities – BE OPEN Regional Art.
  • The artist will be offered a grant of 500 euro from BE OPEN.
  • A self-taught artist born in 1996 has had a passion for drawing and illustration since he was a child.
  • The regional competition runs alongside the regular ongoing work of BE OPEN Art, whose experts every month select 20 new artists for the gallery, and the public names the Artist of the Month and Year.

BE OPEN Art congratulates the winners of the Regional Art Competition in Southeast Asia

Retrieved on: 
Friday, October 13, 2023
Star Awards for Most Popular Regional Artiste, Pseudonym, Region, Henry Newton (Winsor & Newton founder), Month, Baturin (surname), Love, Drawing, BE, Child, Artist, Interior design, Central Africa

LONDON, Oct. 13, 2023 /PRNewswire/ -- BE OPEN Art , an online art gallery set up by BE OPEN think tank, a humanitarian initiative founded by international businessperson and philanthropist Elena Baturina, is running a new competition for emerging artists, aimed to support those whose art best represents their regional, cultural and ethnic identities – BE OPEN Regional Art.

Key Points: 
  • LONDON, Oct. 13, 2023 /PRNewswire/ -- BE OPEN Art , an online art gallery set up by BE OPEN think tank, a humanitarian initiative founded by international businessperson and philanthropist Elena Baturina, is running a new competition for emerging artists, aimed to support those whose art best represents their regional, cultural and ethnic identities – BE OPEN Regional Art.
  • The artist will be offered a grant of 500 euro from BE OPEN.
  • A self-taught artist born in 1996 has had a passion for drawing and illustration since he was a child.
  • The regional competition runs alongside the regular ongoing work of BE OPEN Art, whose experts every month select 20 new artists for the gallery, and the public names the Artist of the Month and Year.

Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa

Retrieved on: 
Thursday, October 12, 2023
Congress, Journal of the European Academy of Dermatology and Venereology, Food, Hidradenitis, UCB, Week, Safety, Classification, Patient, IL-17A, Immunology, Maintenance, Abscess, II, Hidradenitis suppurativa, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Coronavirus, BE, Body mass index, HS, Medical imaging, Pharmaceutical industry, Nursing, Fertilizer, Dermatology, Venereology, Bimekizumab, Allergy

There is a compelling need for new treatment options that can offer high and durable clinical response," said Emmanuel Caeymaex, Executive Vice President, Immunology Solutions and Head of U.S., UCB.

Key Points: 
  • There is a compelling need for new treatment options that can offer high and durable clinical response," said Emmanuel Caeymaex, Executive Vice President, Immunology Solutions and Head of U.S., UCB.
  • "Data presented at EADV showed that over 48 weeks many patients treated with bimekizumab achieved high thresholds of response.
  • These findings suggest that inhibition of IL-17F in addition to IL-17A represents a promising treatment approach in moderate-to-severe hidradenitis suppurativa."
  • "The bimekizumab Phase 3 clinical trial program in hidradenitis suppurativa included the more stringent clinical outcomes of HiSCR75, HiSCR90 and HiSCR100 in addition to the standard HiSCR50.

Castle Biosciences Shares New Data Demonstrating Ability of TissueCypher® Test Results to Inform Clinical Decision-Making in Patients with Non-Dysplastic Barrett’s Esophagus

Retrieved on: 
Monday, October 2, 2023
Oncology, Health, Surgery, Managed Care, Research, Science, Biotechnology, LGD, AFS, Esophagus, Cancer, Radiofrequency ablation, EAC, Incidence, BE, HGD, Dysplasia, HIV disease progression rates, Patient, Physician, Risk, Report, Annual general meeting, Esophageal cancer, Poster, EET, RFA, Pharmaceutical industry, Medical imaging

The data was presented in a poster at the recent American Foregut Society (AFS) Annual Meeting.

Key Points: 
  • The data was presented in a poster at the recent American Foregut Society (AFS) Annual Meeting.
  • The poster, titled “A Tissue Systems Pathology Test Enables Risk-Aligned Management of Patients with Non-Dysplastic Barrett’s Esophagus: Case Reports from a Gastrointestinal Surgery Center,” can be viewed here .
  • The case study reinforced the ability of TissueCypher to identify NDBE patients at high/intermediate risk for progression to HGD/EAC.
  • Identification of NDBE patients with similar progression risk to LGD enables physicians and their patients to consider risk-aligned upstaging of care to prevent development of EAC and improve their overall health outcomes.